Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: Comparison of clinical manifestations, chemotherapeutic responses, and prognosis

E. R. Feldman, R. T. Eagan, Daniel J Schaid

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Between 1975 and 1985, 25 patients with metastatic bronchioloalveolar carcinoma and 223 patients with metastatic adenocarcinoma of the lung received experimental cisplatin-based chemotherapy at the Mayo Clinic. The chemotherapeutic response rates were 32% and 33%, respectively. The median times to progression of disease were identical (3 months in both groups). The median survival times were 4 months and 6 months, respectively. Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung.

Original languageEnglish (US)
Pages (from-to)27-32
Number of pages6
JournalMayo Clinic Proceedings
Volume67
Issue number1
StatePublished - 1992

Fingerprint

Bronchiolo-Alveolar Adenocarcinoma
Cisplatin
Disease Progression
Drug Therapy
Survival
Adenocarcinoma of lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{b06c0365c2234b03830fde08291c98db,
title = "Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: Comparison of clinical manifestations, chemotherapeutic responses, and prognosis",
abstract = "Between 1975 and 1985, 25 patients with metastatic bronchioloalveolar carcinoma and 223 patients with metastatic adenocarcinoma of the lung received experimental cisplatin-based chemotherapy at the Mayo Clinic. The chemotherapeutic response rates were 32{\%} and 33{\%}, respectively. The median times to progression of disease were identical (3 months in both groups). The median survival times were 4 months and 6 months, respectively. Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung.",
author = "Feldman, {E. R.} and Eagan, {R. T.} and Schaid, {Daniel J}",
year = "1992",
language = "English (US)",
volume = "67",
pages = "27--32",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "1",

}

TY - JOUR

T1 - Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung

T2 - Comparison of clinical manifestations, chemotherapeutic responses, and prognosis

AU - Feldman, E. R.

AU - Eagan, R. T.

AU - Schaid, Daniel J

PY - 1992

Y1 - 1992

N2 - Between 1975 and 1985, 25 patients with metastatic bronchioloalveolar carcinoma and 223 patients with metastatic adenocarcinoma of the lung received experimental cisplatin-based chemotherapy at the Mayo Clinic. The chemotherapeutic response rates were 32% and 33%, respectively. The median times to progression of disease were identical (3 months in both groups). The median survival times were 4 months and 6 months, respectively. Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung.

AB - Between 1975 and 1985, 25 patients with metastatic bronchioloalveolar carcinoma and 223 patients with metastatic adenocarcinoma of the lung received experimental cisplatin-based chemotherapy at the Mayo Clinic. The chemotherapeutic response rates were 32% and 33%, respectively. The median times to progression of disease were identical (3 months in both groups). The median survival times were 4 months and 6 months, respectively. Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung.

UR - http://www.scopus.com/inward/record.url?scp=0026575183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026575183&partnerID=8YFLogxK

M3 - Article

C2 - 1310129

AN - SCOPUS:0026575183

VL - 67

SP - 27

EP - 32

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 1

ER -